https://www.biopharmawatch.com/news/VNDA/nereus-sponsor-no-47-indycar-freedom-250-grand-prix BiopharmaWatch en 2026-08-22T19:16:00.000Z NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. https://www.biopharmawatch.com/news/ZURA/zura-bio-inducement-grants-nasdaq-listing-rule BiopharmaWatch en 2026-08-21T23:57:00.000Z Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.biopharmawatch.com/news/CTKB/cytek-biosciences-jury-finds-favor-patent-case BiopharmaWatch en 2026-08-21T20:35:00.000Z Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding https://www.biopharmawatch.com/news/KAPA/kairos-pharma-reverse-stock-split-2026 BiopharmaWatch en 2026-08-21T20:30:00.000Z Kairos Pharma Announces 1-for-7 Reverse Stock Split https://www.biopharmawatch.com/news/ZVRA/zevra-therapeutics-inducement-grants-nasdaq-rule-5635c4 BiopharmaWatch en 2026-08-21T20:30:00.000Z Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)